Kyedgunter6047

Breast cancer (BC) is the most common tumor in women, 523.000 cases were estimated in Europe in 2018 and it remains the third cause of cancer related deaths after lung and colorectal cancer. The incidence of thyroid cancer (TC) in females is higher than in males.

We have retrospectively collected all female patients undergone to surgery for breast or thyroid cancer in 2010The aim of the study was to value the incidence of BC in patients with a personal history of differentiated thyroid cancer (DTC) and conversely, the incidence of DTC in patients with previous BC within 5 years from the diagnosis of the first tumor in 2010.

Among 76 BC patients, 11 were death and 22 didn't answer the phone call or refused to re-submit to thyroid ultrasound so they were excluded from the study and only 43 BC were further considered. Thyroid ultrasound was performed in 2010 and in 2016 and it described nodules in 13 (30%) patients in 2010 and in 21 (49%) patients in 2016. In 2010 no FNA was needed while in 2016 6 (14%) patients underwent to FNA with a benign response (Thyr 2). Among 61 DTC patients, 11 didn't answer the phone or the questions so 50 patients were included in the study. Breast cancer family history was reported in 14 (28%) patients and thyroid cancer family history in 8 (16%) patients. No relapse was reported during follow up.All patients underwent to mammography in 2015 or in 2016 within screening programs and no breast cancer were diagnosed.

The female predominance of diseases of the thyroid and breast makes difficult the separation of an expected association with a casual linkageThe relationship between the co-occurrence of breast and thyroid cancer remains controversial and inconclusive.

Breast cancer, Breast surgery, Hormone therapy, Thyroid cancer, Thyroidectomy.

Breast cancer, Breast surgery, Hormone therapy, Thyroid cancer, Thyroidectomy.

Surgery in association with lymphadenectomy is the treatment of choice for the gastric adenocarcinoma. Aim is to report our experience in the surgical treatment of gastric cancer in a European center.

A prospectively maintained database identified 515 patients. Staging laparoscopy was performed to rule out peritoneal carcinomatosis in suspicious cases. Type of surgery and lymphadenectomy were determined according to the Japanese guidelines and pathological staging according to the TNM classification. Survival was analysed using the Kaplan-Meier method.

Staging laparoscopy avoided 150 (29.1%) unnecessary laparotomies. A total of 356 patients underwent surgery with curative intent. Overall postoperative morbidity and mortality rates were 16.8% and 5.9%, respectively. Two hundred-fifty-one patients (70%) were T3-T4. Negative lymph-nodes were observed in 71 patients (19.9%). One-hundred- seventy-nine were at least stage III. At a mean follow-up of 80.6 months, the overall and disease-free survival rates were 54.4% and 50.6%, respectively. The survival stratification based on the type of lymphadenectomy showed an overall survival rate of 43% and 65.5% in case of D1 and D2 lymphadenectomy, respectively. Based on the tumor stage the overall survival rate was 90%, 62.7%, 36.4% and the disease-free survival was 90%, 54.3%, 31.3%, for stage I, II and III, respectively.

Total or subtotal gastrectomy with D2 lymphadenectomy and adjuvant therapy for the treatment of locally advanced gastric cancer proved a valuable strategy. Staging laparoscopy is recommended.

Gastric cancer, Laparoscopy, Lymphadenectomy, Prognosis, Surgery.

Gastric cancer, Laparoscopy, Lymphadenectomy, Prognosis, Surgery.

The aim of our study was to improve poor results of preliminary colporrhaphy and anterior levatoroplasty performed for patients with low and middle rectocele.

55 patients who had undergone colporrhaphy and anterior levatoroplasty for rectocele in 2012- 2015 and contacted the clinic with complaints of ongoing obstructive defecation were included in this investigation. They had a comprehensive medical examination using defecography, ultrasound, magnetic resonance imaging, anorectal functional tests. This study revealed perineum descending in 20 patients, apical prolapse 23 patients, and 12 patients demonstrated simultaneous pathology. All these patients were performed additional abdominal sacrocolporectopexy in 2015-2017 and results were estimated.

Abdominal sacrocolporectopexy significantly improved anatomical and functional results of previous surgery which was confirmed by the listed methods of research. The average location of the anorectal area and utero-cervical zone became higher. So, perineum descendents and apical prolapsed were improved.

Sacrocolporectopexy is often used for surgical treatment of pelvic organ prolapse. Our study shows its efficiency in patients with perineum descending and upper rectocele.

Abdominal sacrocolporectopexy is an effective method of surgical correction of relapses and unsatisfactory results of treatment of patients with pelvic prolapse, manifested by perineum body descending and apical prolapse.

Apical prolapse, Levatoroplasty, Perineum descending, Rectocele, Sacrocolporectopexy.

Apical prolapse, Levatoroplasty, Perineum descending, Rectocele, Sacrocolporectopexy.

The aim of this study was to present our experiences for anesthesia management in patients undergoing robot-assisted radical prostatectomy (RARP) in light of current literature data.

This clinical retrospective study included 103 patients who underwent robot-assisted radical prostatectomy. Gefitinib EGFR inhibitor All patient data were obtained from the patient files and anesthesia follow-up forms. Demographic datas, intraoperative fluids, blood products requirement and blood gas parameters were recorded.

A total 15 of 103 patients data were lack, the remaining 88 patients were evaluated. Combination of crystalloid and colloid was used for intravenous fluid management. About 11% of patients required transfusion during surgery. The mean pH and pO2 values of the patients were observed to decrease whereas pCO2 and lactate values increased.

Radical Prostatectomy can be performed either using open technique as a traditional approach or laparoscopic or robot-assisted technique as a minimally invasive approach. Today, minimally invasive approaches have replaced traditional open prostatectomy.